Gene · 900
Papers2,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy. | Mol Cancer Ther | 2021 | 34158350 | PubTator, text mining | PubMed |
| Bicycle ownership and utilization in Tamale Metropolis; influencing factors and impacts to sustainable transport. | Heliyon | 2021 | 34141917 | PubTator, text mining | PubMed |
| Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic. | Bioengineered | 2021 | 34130594 | PubTator, text mining | PubMed |
| Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein. | RNA | 2021 | 34127534 | PubTator, text mining | PubMed |
| Role of noncoding RNA in drug resistance of prostate cancer. | Cell Death Dis | 2021 | 34103477 | PubTator, text mining | PubMed |
| Recent progress in targeted delivery vectors based on biomimetic nanoparticles. | Signal Transduct Target Ther | 2021 | 34099630 | PubTator, text mining | PubMed |
| Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer. | J Cancer | 2021 | 34093804 | PubTator, text mining | PubMed |
| MicroRNA Therapeutics in Cancer: Current Advances and Challenges. | Cancers (Basel) | 2021 | 34072348 | PubTator, text mining | PubMed |
| Comprehensive Metabolomic Analysis Reveals Dynamic Metabolic Reprogramming in Hep3B Cells with Aflatoxin B1 Exposure. | Toxins (Basel) | 2021 | 34072178 | PubTator, text mining | PubMed |
| HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. | Cancers (Basel) | 2021 | 34069740 | PubTator, text mining | PubMed |
| Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122. | Cancers (Basel) | 2021 | 34069116 | PubTator, text mining | PubMed |
| Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. | Int J Mol Sci | 2021 | 34068269 | PubTator, text mining | PubMed |
| Rely on Each Other: DNA Binding Cooperativity Shapes p53 Functions in Tumor Suppression and Cancer Therapy. | Cancers (Basel) | 2021 | 34067731 | PubTator, text mining | PubMed |
| Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma. | Int J Mol Sci | 2021 | 34066780 | PubTator, text mining | PubMed |
| A tool for analyzing and visualizing ribo-seq data at the isoform level. | BMC Bioinformatics | 2021 | 34058988 | PubTator, text mining | PubMed |
| Prognosis and Immune Infiltration of Chromobox Family Genes in Sarcoma. | Front Oncol | 2021 | 34046352 | PubTator, text mining | PubMed |
| Role of sex hormones in modulating breast and ovarian cancer associated pain. | Mol Cell Endocrinol | 2021 | 34033890 | PubTator, text mining | PubMed |
| MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2021 | 34012928 | PubTator, text mining | PubMed |
| Cyclin G2, a novel target of sulindac to inhibit cell cycle progression in colorectal cancer. | Genes Dis | 2021 | 33997179 | PubTator, text mining | PubMed |
| The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. | Front Immunol | 2021 | 33995383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/900/papers?page=25